Heimann Larry (19 results)

Pamphlet. Condition: Very Good. Vol 87, No 2, pp. 421-435, 4to, Extracted from orig vol, then Recased in orig journal covers, else VG.

Condition: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail.…

Condition: New. Brand New.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New. In English.

Condition: New.

Hardcover. Condition: Near Fine. Near Fine. 1st US Edition. 188 pages in near fine condition. Pages are clean and unmarked. Purple endpapers. Bound in black cloth with silver titles. Blue and purple dustjacket in near fine condition with white titles. Lightly worn around the edges. 1ST US EDITION. NF/NF. Book. …

Condition: New. The control of the use of beneficial but potentially dangerous technologies by the FDA and NASA Num Pages: 208 pages, 26figs.2tabs. BIC Classification: KN. Category: (P) Professional & Vocational. Dimension: 230 x 160 x 23. Weight in Grams: 545. . 1998. Hardcover. . . . .

Hardback. Condition: New. Complex and risky technologies--technologies such as new drugs for the treatment of AIDS that promise great benefits to our society but carry significant risks--pose many problems for political leaders and the policy makers responsible for overseeing them. Public agencies such as the Food and Drug Administration are told by political superiors not to inhibit important technological advances and may even be charged with promoting such development but must also make sure that no major accidents occur under their watch. Given the large costs associated with catastrophic accidents, the general public and elected officials often demand reliable or failure-free management of these technologies and have little tolerance for the error. Research in this area has lead to a schism between those who argue that it is possible to have reliable management techniques and safely manage complex technologies and others who contend that such control is difficult at best. In this book C. F. Larry Heimann advances an important solution to this problem by developing a general theory of organizational reliability and agency decision making. The book looks at both external and internal influences on reliability in agency decision making. It then tests theoretical propositions developed in a comparative case study of two agencies involved with the handling of risky technologies: NASA and the manned space flight program and the FDA's handling of pharmaceuticals--particularly new AIDS therapies. Drawing on concepts from engineering, organizational theory, political science, and decision theory, this book will be of interest to those interested in science and technology policy, bureaucratic management and reform, as well as those interested in health and space policy. C. F. Larry Heimann is Assistant Professor of Political Science, Michigan State University.…

Condition: As New. Unread book in perfect condition.

Hardcover. Condition: Brand New. 188 pages. 9.50x6.50x1.00 inches. In Stock.

Hardback. Condition: New. New copy - Usually dispatched within 4 working days.

Condition: New. The control of the use of beneficial but potentially dangerous technologies by the FDA and NASA Num Pages: 208 pages, 26figs.2tabs. BIC Classification: KN. Category: (P) Professional & Vocational. Dimension: 230 x 160 x 23. Weight in Grams: 545. . 1998. Hardcover. . . . . Books ship from the US and Ireland.…

Hardcover. Condition: Good. Good .Ships From Multiple Locations. book.

Condition: New. pp. 208.

Condition: New. pp. 208.

Hardback. Condition: New. Complex and risky technologies--technologies such as new drugs for the treatment of AIDS that promise great benefits to our society but carry significant risks--pose many problems for political leaders and the policy makers responsible for overseeing them. Public agencies such as the Food and Drug Administration are told by political superiors not to inhibit important technological advances and may even be charged with promoting such development but must also make sure that no major accidents occur under their watch. Given the large costs associated with catastrophic accidents, the general public and elected officials often demand reliable or failure-free management of these technologies and have little tolerance for the error. Research in this area has lead to a schism between those who argue that it is possible to have reliable management techniques and safely manage complex technologies and others who contend that such control is difficult at best. In this book C. F. Larry Heimann advances an important solution to this problem by developing a general theory of organizational reliability and agency decision making. The book looks at both external and internal influences on reliability in agency decision making. It then tests theoretical propositions developed in a comparative case study of two agencies involved with the handling of risky technologies: NASA and the manned space flight program and the FDA's handling of pharmaceuticals--particularly new AIDS therapies. Drawing on concepts from engineering, organizational theory, political science, and decision theory, this book will be of interest to those interested in science and technology policy, bureaucratic management and reform, as well as those interested in health and space policy. C. F. Larry Heimann is Assistant Professor of Political Science, Michigan State University.…